Healthcare Services

Hypertrophic And Keloid Scar Treatment Market Expected To Witness Revenue Growth Toward $13.76 Billion By 2030

May 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Growth In Market Size Of The Hypertrophic And Keloid Scar Treatment Market During 2026–2030?

The hypertrophic and keloid scar treatment market has observed robust growth in recent years. Its valuation is set to climb from $8.49 billion in 2025 to $9.33 billion in 2026, propelled by a compound annual growth rate (CAGR) of 9.9%. This historical expansion can be attributed to an increasing frequency of surgical procedures, a rise in the occurrence of trauma and burns, the widespread adoption of corticosteroid injections, the expansion of dermatology and cosmetic clinics, and the clearly noticeable aesthetic impact scars have.

The hypertrophic and keloid scar treatment market is projected to experience significant growth in the coming years. It is expected to reach $13.77 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.2%. This growth during the forecast period can be attributed to factors such as a growing preference for non-invasive scar treatments, the increasing adoption of laser and radiotherapy techniques, rising awareness of early scar management, the expansion of combination treatment protocols, and improving access to advanced dermatology services. Major trends anticipated in the forecast period include the increasing adoption of combination scar management therapies, a rising demand for minimally invasive and non-surgical treatments, the growing use of laser and energy-based scar revision techniques, the expansion of post-surgical and preventive scar care solutions, and a heightened focus on early intervention and long-term scar control.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10692&type=smp

What Core Drivers Are Transforming The Hypertrophic And Keloid Scar Treatment Market?

The hypertrophic and keloid scar treatment market is anticipated to expand due to a rising incidence of road accidents and burn cases. Road incidents typically involve a vehicle and individuals on the road, while both road accidents and burn cases necessitate immediate attention, preventive strategies, and efficient medical interventions. Hypertrophic and keloid scar treatments are crucial for individuals injured in road accidents, working to reduce the prominence and firmness of scars. A surge in these types of injuries consequently fuels the expansion of the hypertrophic and keloid scar treatment market. Illustrating this, The Health Foundation, an independent UK organization, stated in January 2025 that 2023 data showed 43 serious or fatal casualties per billion miles traveled by car, alongside 1,032 for cyclists and 1,914 for motorcyclists. Furthermore, 92 pedestrians per million residents sustained fatal or serious injuries. Consequently, the growing frequency of road accidents and burn cases will be a key driver for the hypertrophic and keloid scar treatment market.

What Segment Types Are Included In The Hypertrophic And Keloid Scar Treatment Market Analysis?

The hypertrophic and keloid scar treatment market covered in this report is segmented –

1) By Treatment: Cryotherapy, Surgical Excision, Pressure Dressings, Intralesional 5-Fluorouracil, Superficial X-Ray, Intralesional Corticosteroid Injection, Other Treatments

2) By Products: Topical Products, Laser Products, Injectables, Other Products

3) By Scar: Hypertrophic Scars, Keloid Scars

4) By End-Use: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Cryotherapy, Intralesional Cryotherapy

2) By Surgical Excision: Simple Excision, Excision With Skin Grafting

3) By Pressure Dressings: Elastic Bandage Pressure Dressings, Silicone Gel Pressure Dressings

4) By Intralesional 5-Fluorouracil: Standalone 5-FU Treatment, Combination With Corticosteroids

5) By Superficial X-Ray: Low-Dose X-Ray Therapy, Combination X-Ray With Other Treatments

6) By Intralesional Corticosteroid Injection: Triamcinolone Acetonide Injection, Combination With 5-Fluorouracil

7) By Other Treatments: Laser Therapy, Radiotherapy, Interferon Therapy

Which Trends Are Guiding The Development Of The Hypertrophic And Keloid Scar Treatment Market?

Leading companies in the hypertrophic and keloid scar treatment market are concentrating on developing clinically verified silicon-based solutions, such as medical-grade silicone strips, to maximize their financial gains. Medical-grade silicone strips are therapeutic items crafted from high-quality silicone material, specifically formulated to encourage scar healing and reduction. For example, in April 2023, Scar Erase, a UK-based company providing silicone-based scar reduction therapy, launched its Scar Erase silicone strips, presenting a clinically tested and affordable option for scar healing. Made from 3mm of medical-grade silicone, these strips assist in the treatment of diverse scar types, including hypertrophic, keloid, post-surgery, and stretch marks. This silicone technology effectively encases the scar area, promoting hydration and an optimal healing environment, resulting in significant improvements in scar texture, color, and height. It is engineered for comfort and discretion, offering an accessible at-home scar treatment solution.

Which Organizations Are Operating Within The Hypertrophic And Keloid Scar Treatment Market?

Major companies operating in the hypertrophic and keloid scar treatment market are Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Stratpharma AG, Biodermis, Mederma, Silagen

Access The Complete Hypertrophic And Keloid Scar Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/hypertrophic-and-keloid-scar-treatment-global-market-report

Which Region Commands The Largest Share Of The Hypertrophic And Keloid Scar Treatment Market?

North America was the largest region in the hypertrophic and keloid scar treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Hypertrophic And Keloid Scar Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=10692&type=smp

Browse Through More Reports Similar to the Global Hypertrophic And Keloid Scar Treatment Market 2026, By The Business Research Company

Scar Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/scar-treatment-global-market-report

Keloids Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/keloids-treatment-global-market-report

Neurotrophic Keratitis Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurotrophic-keratitis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795